Table 3.

Influence of γ-secretase inhibition by DAPT on frequency of cell subsets in FTOC seeded with human CD34+CD1- thymic progenitor cells after 13 and 19 days of culture




DAPT treatment
Cell subset
Control
5 μM
10 μM
After 13 days    
   CD4ISP   57.3 ± 1.7   43.0 ± 2.6   35.3 ± 0.8  
   DP   14.7 ± 6.0   52.6 ± 5.4*  56.7 ± 0.6* 
   IC TCR-β   26.3 ± 7.1   1.3 ± 0.1*  0.9 ± 0.2* 
   CD3+  17.9 ± 4.6   1.0 ± 0.2*  0.8 ± 0.2* 
   TCR-αβ   1.3 ± 0.3   0.5 ± 0.1*  0.3 ± 0.1* 
   TCR-γδ   4.0 ± 0.5   0.2 ± 0.1*  0.1 ± 0.0* 
After 19 days    
   CD56+  0.2 ± 0.1   2.7 ± 0.3*  8.3 ± 2.1* 
   CD4ISP   34.4 ± 6.3   16.6 ± 5.2*  8.7 ± 2.0* 
   DP   56.3 ± 9.3   68.9 ± 8.8*  71.1 ± 3.6* 
   IC TCR-β   63.4 ± 7.1   5.3 ± 1.2*  2.1 ± 1.7* 
   CD3+  50.6 ± 3.5   5.1 ± 0.5*  5.1 ± 0.8* 
   TCR-αβ   36.8 ± 3.8   2.3 ± 0.6*  2.3 ± 0.5* 
   TCR-γδ
 
3.3 ± 0.9
 
0.4 ± 0.1*
 
0.9 ± 0.5*
 



DAPT treatment
Cell subset
Control
5 μM
10 μM
After 13 days    
   CD4ISP   57.3 ± 1.7   43.0 ± 2.6   35.3 ± 0.8  
   DP   14.7 ± 6.0   52.6 ± 5.4*  56.7 ± 0.6* 
   IC TCR-β   26.3 ± 7.1   1.3 ± 0.1*  0.9 ± 0.2* 
   CD3+  17.9 ± 4.6   1.0 ± 0.2*  0.8 ± 0.2* 
   TCR-αβ   1.3 ± 0.3   0.5 ± 0.1*  0.3 ± 0.1* 
   TCR-γδ   4.0 ± 0.5   0.2 ± 0.1*  0.1 ± 0.0* 
After 19 days    
   CD56+  0.2 ± 0.1   2.7 ± 0.3*  8.3 ± 2.1* 
   CD4ISP   34.4 ± 6.3   16.6 ± 5.2*  8.7 ± 2.0* 
   DP   56.3 ± 9.3   68.9 ± 8.8*  71.1 ± 3.6* 
   IC TCR-β   63.4 ± 7.1   5.3 ± 1.2*  2.1 ± 1.7* 
   CD3+  50.6 ± 3.5   5.1 ± 0.5*  5.1 ± 0.8* 
   TCR-αβ   36.8 ± 3.8   2.3 ± 0.6*  2.3 ± 0.5* 
   TCR-γδ
 
3.3 ± 0.9
 
0.4 ± 0.1*
 
0.9 ± 0.5*
 

Results represent mean percentage ± SEM of 3 to 5 independent experiments.

*

Significant difference (P < .05; paired Student t test) compared with vehicle-treated control cultures

or Create an Account

Close Modal
Close Modal